CNTB
Connect Biopharma Holdings Limited
NASDAQ · Healthcare · Biotechnology · CN
$1.84
−4.66%Margins
Gross margin
100.0%
EBITDA margin
-1984.8%
EBIT margin
-2057.6%
Net margin
-1998.3%
FCF margin
-1648.4%
-274.0%
Return on equity
-169.3%
Return on assets
-276.0%
Return on invested capital
0.07x
Asset turnover
-$60.1M
Cash from operations
$0.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026